South Carolina Code of Regulations › Chapter 61 - DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL › Subchapter 61-79 - Hazardous Waste Management Regulations › Part 61-79.266 - STANDARDS FOR THE MANAGEMENT OF SPECIFIC HAZARDOUS WASTES AND SPECIFIC TYPES OF HAZARDOUS WASTE MANAGEMENT FACILITIES › Subpart P - HAZARDOUS WASTE PHARMACEUTICALS › Section 61-79.266.P.509 - Shipping potentially creditable hazardous waste pharmaceuticals from a healthcare facility or a reverse distributor to a reverse distributor

Current through Register Vol. 48, No. 6, June 28, 2024
(a) Shipping
				  potentially creditable hazardous waste pharmaceuticals. A healthcare facility
				  or a reverse distributor who transports or offers for transport potentially
				  creditable hazardous waste pharmaceuticals off-site to a reverse distributor
				  must comply with all applicable U.S. Department of Transportation regulations
				  in 49 CFR part 171 through 180 for any potentially creditable hazardous waste
				  pharmaceutical that meets the definition of hazardous material in
				  49 CFR
				  171.8. For purposes of the U.S. Department of
				  Transportation regulations, a material is considered a hazardous waste if it is
				  subject to the Hazardous Waste Manifest Requirements of the U.S. Environmental
				  Protection Agency specified in 40 CFR part 262. Because a potentially
				  creditable hazardous waste pharmaceutical does not require a manifest, it is
				  not considered hazardous waste under the U.S. Department of Transportation
				  regulations.
(b) Delivery
				  confirmation. Upon receipt of each shipment of potentially creditable hazardous
				  waste pharmaceuticals, the receiving reverse distributor must provide
				  confirmation (paper or electronic) to the healthcare facility or reverse
				  distributor that initiated the shipment that the shipment of potentially
				  creditable hazardous waste pharmaceuticals has arrived at its destination and
				  is under the custody and control of the reverse distributor.
(c) Procedures for when delivery confirmation
				  is not received within thirty-five (35) calendar days. If a healthcare facility
				  or reverse distributor initiates a shipment of potentially creditable hazardous
				  waste pharmaceuticals to a reverse distributor and does not receive delivery
				  confirmation within thirty-five (35) calendar days from the date that the
				  shipment of potentially creditable hazardous waste pharmaceuticals was sent,
				  the healthcare facility or reverse distributor that initiated the shipment must
				  contact the carrier and the intended recipient (i.e., the reverse distributor)
				  promptly to report that the delivery confirmation was not received and to
				  determine the status of the potentially creditable hazardous waste
				  pharmaceuticals.
(d) Exporting
				  potentially creditable hazardous waste pharmaceuticals. A healthcare facility
				  or reverse distributor that sends potentially creditable hazardous waste
				  pharmaceuticals to a foreign destination must comply with the applicable
				  section s of part 262, subpart H, except the manifesting requirement of section
				  262.83(c), in addition to paragraphs (a) through (c) of this section
				  .
(e) Importing potentially
				  creditable hazardous waste pharmaceuticals. Any person that imports potentially
				  creditable hazardous waste pharmaceuticals into the United States is subject to
				  paragraphs (a) through (c) of this section in lieu of part 262, subpart H.
				  Immediately after the potentially creditable hazardous waste pharmaceuticals
				  enter the United States, they are subject to all applicable requirements of
				  this subpart.